Propofol in a modified cyclodextrin formulation: First human study of dose-response with emphasis on injection pain

Anesthesia and Analgesia

Volumn 113, Issue 4, 2011, Pages 738-741

  Wallentine, Crystal B ^a   Shimode, Noriko ^b   Egan, Talmage D ^a   Pace, Nathan L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; PROPOFOL;

ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION PAIN; MALE; NORMAL HUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION;

EID: 80053298023     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31822b8648     Document Type: Article

References (19)

1. Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology. 2005; 103: 860-76. (Pubitemid 41415536)
2. McLeskey CH, Walawander CA, Nahrwold ML, Roizen MF, Stanley TH, Thisted RA, White PF, Apfelbaum JL, Grasela TH, Hug CC Jr. Adverse events in a multicenter phase IV study of propofol: evaluation by anesthesiologists and postanesthesia care unit nurses. Anesth Analg 1993;77:S3-9 (Pubitemid 23286440)
3. Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia 1998;53:468-76 (Pubitemid 28223077)
4. Eddleston JM, Shelly MP. The effect on serum lipid concentrations of a prolonged infusion of propofol-hypertriglyceridaemia associated with propofol administration. Intensive Care Med 1991;17:424-6
5. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, Gueant JL. Life-threatening anaphylactoid reactions to propofol (Diprivan) [see comments]. Anesthesiology 1992;77:275-80
6. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L, Zeitz PS, Jarvis WR. Postoperative infections traced to contamination of an intravenous anesthetic, propofol [see comments]. N Engl J Med 1995;333:147-54
7. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 1993;77:766-8 (Pubitemid 23291894)
8. Egan TD, Kern SE, Johnson KB, Pace NL. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model. Anesth Analg 2003;97:72-9 (Pubitemid 36736541)
9. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999;89:652-8 (Pubitemid 29409815)
10. Egan TD. Exploring the frontiers of propofol formulation strategy: is there life beyond the Milky Way? Br J Anaesth 2010;104:533-5
11. Doenicke AW, Roizen MF, Rau J, Kellermann W, Babl J. Reducing pain during propofol injection: the role of the solvent. Anesth Analg 1996;82:472-4 (Pubitemid 26072946)
12. Doenicke AW, Roizen MF, Rau J, ÓConnor M, Kugler J, Klotz U, Babl J. Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg 1997;85:1399-403 (Pubitemid 28130547)
13. Sim JY, Lee SH, Park DY, Jung JA, Ki KH, Lee DH, Noh GJ. Pain on injection with microemulsion propofol. Br J Clin Pharmacol 2009;67:316-25
14. Song D, Hamza M, White PF, Klein K, Recart A, Khodaparast O. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion. Anesth Analg 2004;98:687-91 (Pubitemid 38252659)
15. Tramer MR, Moore RA, McQuay HJ. Propofol and bradycardia: causation, frequency and severity. Br J Anaesth 1997;78: 642-51 (Pubitemid 27268072)
16. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 2007;104:13525-30 (Pubitemid 47293978)
17. Lee SP, Buber MT, Yang Q, Cerne R, Cortes RY, Sprous DG, Bryant RW. Thymol and related alkyl phenols activate the hTRPA1 channel. Br J Pharmacol 2008;153:1739-49 (Pubitemid 351536006)
18. Erden V, Basaranoglu G, Korkut Y, Delatioglu H, Yangin Z, Kiroglu S. Relation between bitter taste sensitivity and incidence or intensity of propofol injection pain. Eur J Anaesthesiol 2007;24:516-20 (Pubitemid 46787789)
19. Fischer MJ, Leffler A, Niedermirtl F, Kistner K, Eberhardt M, Reeh PW, Nau C. The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem 2010;285:34781-92